ebook Munafa Stock Market Course + Intraday & FNO calls  

       

FHTX announcements Foghorn Therapeutics Inc announcements and dividends declared NASDAQ

Foghorn Therapeutics Inc Complete list of announcements declared & dividend announcements by Foghorn Therapeutics Inc FHTX

Foghorn Therapeutics Inc FHTX listed on NASDAQ and deals in

Announcements and dividends declared by Foghorn Therapeutics Inc FHTX

Foghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Lags Revenue Estimates
Foghorn Therapeutics (FHTX) delivered earnings and revenue surprises of -3.45% and 75.63%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Announcement as on 06 March 2025

Strength Seen in Foghorn Therapeutics (FHTX): Can Its 9.5% Jump Turn into More Strength?
Foghorn Therapeutics Inc. (FHTX) shares rallied 9.5% in the last trading session to close at .72. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compar
Announcement as on 16 September 2024

Foghorn Therapeutics Inc. (FHTX) Surges 12.8%: Is This an Indication of Further Gains?
Foghorn Therapeutics Inc. FHTX shares rallied 12.8% in the last trading session to close at .69. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compare
Announcement as on 09 July 2023

HC Wainwright & Co. Reiterates Foghorn Therapeutics (FHTX) Buy Recommendation
Fintel reports that on June 28, 2023, HC Wainwright & Co. reiterated coverage of Foghorn Therapeutics (NASDAQ:FHTX) with a Buy recommendation.
Announcement as on 29 June 2023

: Foghorn Therapeutics stock slides 21% after FDA puts partial clinical hold on cancer drug trial
Foghorn Therapeutics Inc.’s stock FHTX slid 21% in premarket trade Monday, after the biotech said the Food and Drug Administration has placed a partial hold on a cancer trial. The company is pausing enrollment in the trial of its FHD-609 therapy in synov
Announcement as on 24 April 2023

Announcements by Foghorn Therapeutics Inc first page | Next page |

FHTX Foghorn Therapeutics Inc current price & indicator signals

Moving Averages for Foghorn Therapeutics Inc

  • 5Day Average: 5.11
  • 12Day Average: 5.24
  • 20Day Average: 5.06
  • 50Day Average: 4.7
  • 100Day Average: 4.76
  • 150Day Average: 4.9
  • 200Day Average: 4.66

FHTX Indicators & signals

Indicator MACD (12,26,9)

5.14, 5, 0.16
Indicator MACD is in positive zone

Indicator ADX (14)

12.5, 25.71, 20
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 57
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of FHTX Foghorn Therapeutics Inc are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
09 Fri Jan 2026 5.16 5.04 to 5.30 -1.34% 1.23 times
08 Thu Jan 2026 5.23 5.02 to 5.25 -0.57% 1.29 times
07 Wed Jan 2026 5.26 4.99 to 5.37 6.69% 0.73 times
06 Tue Jan 2026 4.93 4.64 to 4.98 -1% 1.45 times
05 Mon Jan 2026 4.98 4.95 to 5.32 -4.05% 1.5 times
02 Fri Jan 2026 5.19 5.12 to 5.48 -3.89% 0.68 times
31 Wed Dec 2025 5.40 5.15 to 5.54 4.85% 1.09 times
30 Tue Dec 2025 5.15 5.01 to 5.23 -0.77% 1.25 times
29 Mon Dec 2025 5.19 5.05 to 5.33 -3.89% 0.95 times
26 Fri Dec 2025 5.40 5.30 to 5.51 0% 0.52 times
24 Wed Dec 2025 5.40 5.25 to 5.54 -2.7% 0.54 times
23 Tue Dec 2025 5.55 5.48 to 5.91 -3.98% 0.85 times

Videos related to: FHTX announcements Foghorn Therapeutics Inc announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

FHTX announcements Foghorn Therapeutics Inc announcements and dividends declared NASDAQ

 

Back to top